124 related articles for article (PubMed ID: 22808803)
21. Asymptomatic inflammation and/or infection in benign prostatic inflammation.
Irani J; Goujon JM
BJU Int; 2000 Jun; 85(9):1155-6. PubMed ID: 10939872
[No Abstract] [Full Text] [Related]
22. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?
Mishra VC; Allen DJ; Nicolaou C; Sharif H; Hudd C; Karim OM; Motiwala HG; Laniado ME
BJU Int; 2007 Aug; 100(2):327-31. PubMed ID: 17617139
[TBL] [Abstract][Full Text] [Related]
23. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress--cause or consequence of male genital tract disorders?
Kullisaar T; Türk S; Punab M; Mändar R
Prostate; 2012 Jun; 72(9):977-83. PubMed ID: 22025397
[TBL] [Abstract][Full Text] [Related]
25. [Inflammatory changes in the obstructed prostate: the correlation between the bacteriological and histological findings].
Soler Soler JL; Martínez Torres JL; Hidalgo Domínguez Mdel R; Lardelli Claret P; Liébana Ureña J; Zuluaga Gómez A; Saharour G
Arch Esp Urol; 1999 Sep; 52(7):729-38. PubMed ID: 10540763
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of benign prostate hyperplasia with prostatitis].
Long Z; He L; Zhong K; Zhang Y; Yue D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):381-5. PubMed ID: 20448364
[TBL] [Abstract][Full Text] [Related]
27. [Expressions of integrinalpha2beta1 and CD133 in benign prostatic hyperplasia complicated by prostatitis and their significance].
Ding Q; Miao WL; Liu S; Chang JW; Yang YM
Zhonghua Nan Ke Xue; 2011 Oct; 17(10):909-12. PubMed ID: 22049795
[TBL] [Abstract][Full Text] [Related]
28. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Rosen RC; Fitzpatrick JM;
BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
[TBL] [Abstract][Full Text] [Related]
29. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
30. Histopathological review of prostatic diseases in Kano, Nigeria.
Mohammed AZ; Alhassan SU; Edino ST; Ochicha O
Niger Postgrad Med J; 2003 Mar; 10(1):1-5. PubMed ID: 12717456
[TBL] [Abstract][Full Text] [Related]
31. Prostate growth and inflammation.
Sciarra A; Mariotti G; Salciccia S; Autran Gomez A; Monti S; Toscano V; Di Silverio F
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):254-60. PubMed ID: 17935971
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
[TBL] [Abstract][Full Text] [Related]
33. Prostate inflammation. Association with benign prostatic hyperplasia and prostate cancer.
Abdel-Meguid TA; Mosli HA; Al-Maghrabi JA
Saudi Med J; 2009 Dec; 30(12):1563-7. PubMed ID: 19936421
[TBL] [Abstract][Full Text] [Related]
34. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
[TBL] [Abstract][Full Text] [Related]
35. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
Rosen RC
Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
[TBL] [Abstract][Full Text] [Related]
36. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gallegos PJ; Frazee LA
Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
[TBL] [Abstract][Full Text] [Related]
37. [Nonspecific granulomatous prostatitis. Histopathological study of 53 cases with a review of the literature].
Mbakop A; Reverdin N; Cox JN
Schweiz Med Wochenschr; 1985 Apr; 115(15):522-5. PubMed ID: 2581313
[TBL] [Abstract][Full Text] [Related]
38. [Transurethral resection in patients with benign prostatic hyperplasia complicated by chronic calculous prostatitis].
Trapeznikova MF; Bazaev VV; Urenkov SB
Urol Nefrol (Mosk); 1997; (1):28-31. PubMed ID: 9123662
[TBL] [Abstract][Full Text] [Related]
39. [Inflammation and benign prostatic hyperplasia: cause or consequence?].
Robert G; Salagierski M; Schalken JA; de La Taille A
Prog Urol; 2010 Jun; 20(6):402-7. PubMed ID: 20538203
[TBL] [Abstract][Full Text] [Related]
40. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
